“Theaflavin-2,
the component of black tea extract, triggered cancer cell death (apoptosis),
inducing shrinkage of cancer cells within 3 hours of treatment. When the
researchers looked at a specific set of genes that kill cancer cells, Theaflavin-2
was found to up-regulate or activate these genes. The study also showed the
ability of Theaflavin-2 to suppress the activity of a gene that induces the
inflammatory enzyme cyclooxygenase (COX) 2 while also reducing the activity of
other inflammatory molecules (such as TNF-α and nuclear factor-kappa B (NF-KB).
Theaflavin-2 was also shown to reduce inflammation and also produced a pattern
of gene regulation similar to that found in the cancer cells. These results
suggest that Theaflavin-2, a major component of black tea has the capacity to help
kill cancer cells through mechanisms involving gene regulation and an
anti-inflammatory effect.
“In the second
study,2 researchers from India examined the effect of
polyphenols from both black and green tea on the development of breast cancer
(mammary tumours) in female rats. Both black and green tea polyphenols
significantly reduced the number of mammary tumours by 77% and 92% respectively
as well as reducing their growth. When the potential mechanisms for these
benefits were investigated, both black and green tea polyphenols were found to
scavenge reactive oxygen species by 69% and 72% respectively by inhibiting the
inflammatory COX enzyme and inactivating an inflammatory molecule, technically
known as NF-KB.
“Taken together,
these two studies have demonstrated that components of black tea can help shrink
and kill cancer cells and/or result in helping to reduce the number of tumours.
These studies indicate that these effects are associated with the ability of
black tea components to regulate genes, reduce the activity of COX, an
inflammatory enzyme, and reduce the activity of inflammatory substances such as
NF-KB.”
In summary, Dr Bond adds: “These findings
suggest the need for clinical trials to evaluate the effect of black tea and
its components on the risk of cancer in humans. In particular, new studies are
needed to evaluate the bioavailability of theaflavins and the clinical effects
of their metabolic degradation products to shed further light on both
mechanisms of action and clinical applications of black tea ingredients. In the
meantime, drinking black tea, the UK ’s most popular beverage, can
continue to be recommended for its many health benefits including the
possibility that it could contribute to reducing the risk of cancer.”
The Tea
Advisory Panel: The Tea Advisory Panel is supported by an unrestricted
educational grant from the UK TEA
COUNCIL, the trade association for the UK tea industry. The Panel has been
created to provide media with impartial information regarding the health
benefits of tea. Panel members include nutritionists; dieticians and
doctors. For further information please call 0207 7052 8989.
[1] Gosslau A, En Jao DL,
Ho CT et al. Effects of the
black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in
vitro and in vivo. Mol Nutr Food Res 2011; 55(2)198-208
[2] Roy P, George J, Srivastava S et al.
Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through
regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumours.
Invest New Drugs 2011; 29(2) 225-231.
No comments:
Post a Comment